Results 221 to 230 of about 3,725,370 (324)
We developed and validated a DNA methylation–based biomarker panel to distinguish pleural mesothelioma from other pleural conditions. Using the IMPRESS technology, we translated this panel into a clinically applicable assay. The resulting two classifier models demonstrated excellent performance, achieving high AUC values and strong diagnostic accuracy.
Janah Vandenhoeck +12 more
wiley +1 more source
Concerns of first-year medical students regarding their future profession: an international study. [PDF]
Neumaier V +9 more
europepmc +1 more source
Ranked Choice Voting in Alameda County : A Natural Experiment
Bo Hellekant
openalex +1 more source
The shift-homological spectrum and parametrising kernels of rank functions [PDF]
Isaac Bird +2 more
openalex +1 more source
Strength through diversity: how cancers thrive when clones cooperate
Intratumor heterogeneity can offer direct benefits to the tumor through cooperation between different clones. In this review, Kuiken et al. discuss existing evidence for clonal cooperativity to identify overarching principles, and highlight how novel technological developments could address remaining open questions.
Marije C. Kuiken +3 more
wiley +1 more source
The F score ranks diagnostic tests and prediction models inconsistently with their clinical utility. [PDF]
Assel M, Vickers A.
europepmc +1 more source
Symmetric Rank-One Quasi-Newton Methods for Deep Learning Using Cubic Regularization [PDF]
Aditya Ranganath +2 more
openalex +1 more source
We developed a cost‐effective methylation‐specific droplet digital PCR multiplex assay containing tissue‐conserved and tumor‐specific methylation markers. The assay can detect circulating tumor DNA with high accuracy in patients with localized and metastatic colorectal cancer.
Luisa Matos do Canto +8 more
wiley +1 more source
A drug-repurposing screen of FDA- and EMA-approved drugs identifies two NF-κB inhibitors active against eumycetoma. [PDF]
Ma J +5 more
europepmc +1 more source

